NCT05826379
Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife
Enrolling by Invitation
NAAges 30–70InterventionalBasic scienceMilton S. Hershey Medical CenterInvestigator-initiated
~200 participants
Updated 2026-05-11 on ClinicalTrials.gov
What's tested:Adaptive Daily Goal SettingInterim Goal Prompt
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Short-term adherence
Measured over 1-month follow-up
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Jonathan G Hakun, PhD · PRINCIPAL_INVESTIGATOR · Milton S. Hershey Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Between 30 and 70 years of age
BMI ≥ 25
Exclusion
Clinical diagnosis of ADRD or other neurodegenerative disease
Health condition contraindicated for increased physical activity
Medical conditions or medications that would prohibit participation in an exercise test (e.g., decompensated heart failure, severe aortic stenosis, uncontrolled arrhythmia, and acute coronary syndromes)
Limitations in use of a smart phone (e.g., issues with manual dexterity or visual impairment)
Inability to walk unassisted
BMI \> 50
Plan to have surgery or other procedure over the next 12 months that could affect mobility or light intensity physical activity maintenance
Concurrent participation in a weight loss, physical activity, or cognitive training trial
Failure to comply with Run-in Period activity monitoring (\<70% valid wear days for the Fitbit and activPal)
Anyone who will not discontinue the use of their own personal smartwatch during the training period.
Anyone who scores below 19 on the MoCA-B would not be randomized after the Run-in Calibration Period.
What this trial measures
- Short-term adherence1-month follow-up
Average of 14-day step count totals collected via ActivPal monitors
- Long-term adherence12-month follow-up
Average of 14-day step count totals collected via ActivPal monitors